Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Outset Medical, Inc.OM · Entity 7026 | Chief Technology Officer | May 10, 2024 | May 10, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Outset Medical, Inc.
Report date May 10, 2024 · Filed May 10, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 265,325 |
Reported balance
After 2024-05-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-05-10 · Sale · Disposed 8,306 · Balance 265,325 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2024 Filed May 10, 2024 22:19 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 8,306 | $3.27 | $27,160.62 |
DisclosureSEC source: 0001484612-24-000041 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,325 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 22:28 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,866 | $3.57 | $6,661.62 |
DisclosureSEC source: 0001484612-24-000030 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,830 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 6,210 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 01:03 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 723 | $4.29 | $3,101.67 |
DisclosureSEC source: 0001484612-24-000018 · edgardoc.xml · nonDerivative · entry 4 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,696 F4 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (3) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:03 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 4,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000018 · edgardoc.xml · nonDerivative · entry 3 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,419 F3 · shares: On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:03 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000018 · edgardoc.xml · nonDerivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,781 F2 · shares: Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock. Read SEC document |
| January 12, 2024 Filed Jan 18, 2024 01:03 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 96,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000018 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,781 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 01:33 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 3,905 | $5.49 | $21,438.45 |
DisclosureSEC source: 0001484612-24-000010 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,781 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 12,944 shares of Common Stock underlying RSUs granted to the reporting person on January 6, 2023. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:18 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 790 | $4.76 | $3,760.40 |
DisclosureSEC source: 0001484612-23-000089 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,686 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,971 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 1 share of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of March 1, 2023 to August 31, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| August 16, 2023 Filed Aug 17, 2023 20:39 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 752 | $15.10 | $11,355.20 |
DisclosureSEC source: 0001484612-23-000071 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,475 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 2,971 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021 and January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. Read SEC document |
| May 16, 2023 Filed May 17, 2023 00:35 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 735 | $19.91 | $14,633.85 |
DisclosureSEC source: 0001484612-23-000040 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,227 F1 · price: The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. F2 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:42 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 297 | $24.36 | $7,234.92 |
DisclosureSEC source: 0001484612-23-000022 · edgardoc.xml · nonDerivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,540 F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 01:42 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 451 | $24.36 | $10,986.36 |
DisclosureSEC source: 0001484612-23-000022 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,837 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,791 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 27, 2023 Filed Jan 30, 2023 21:44 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 2,066 | $27.92 | $57,682.72 |
DisclosureSEC source: 0001484612-23-000013 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,288 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 7,162 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:56 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000008 · edgardoc.xml · nonDerivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,354 F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 21:56 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 38,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000008 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,170 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 21:26 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 292 | $19.29 | $5,632.68 |
DisclosureSEC source: 0001484612-22-000077 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,336 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 22:17 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 292 | $21.48 | $6,272.16 |
DisclosureSEC source: 0001484612-22-000065 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,628 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,180 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| June 23, 2022 Filed Jun 24, 2022 21:33 UTC | Outset Medical, Inc. OM · Entity 7026 | SaleCommon Stock | 1,157 | $14.50 | $16,776.50 |
DisclosureSEC source: 0001484612-22-000057 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,920 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 4,719 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Includes 500 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2021 to February 28, 2022. This transaction is exempt from Rule 16b-3(c). Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:47 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 1,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000011 · edgardoc.xml · nonDerivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,577 F2 · shares: Represents portion of stock units granted to the reporting person on January 26, 2022 that will vest on December 31, 2024, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| January 26, 2022 Filed Jan 28, 2022 21:47 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 21,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000011 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,368 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 26, 2022. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 26, 2023, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:16 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 34,220 | $0.00 Strike: $50.82 | $0.00 |
DisclosureSEC source: 0001484612-21-000033 · edgardoc.xml · derivative · entry 2 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,220 Underlying: Common Stock · 34,220 shares Expires 2031-06-22 F2 · derivative.exercise_date: This option vests 25% on June 22, 2022 and then in 36 equal monthly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 20:16 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 18,879 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-21-000033 · edgardoc.xml · nonDerivative · entry 1 Racine Jean-Olivier · CIK 0001868039 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,879 F1 · shares: Represent Restricted Stock Units (RSUs) granted to the reporting person on June 22, 2021. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 25% on June 22, 2022, then quarterly over three years on each February 15th, May 15th, August 15h and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.